{"id":974888,"date":"2026-06-23T11:55:15","date_gmt":"2026-06-23T15:55:15","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss-3\/"},"modified":"2026-06-23T11:55:15","modified_gmt":"2026-06-23T15:55:15","slug":"embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss-3","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss-3\/","title":{"rendered":"Embecta Corp. (EMBC) Faces Securities Class Action for Allegedly Concealing Competitive Threats to Pen Needle Business &#8212; HBSS"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\">SAN FRANCISCO<\/span>, <span class=\"legendSpanClass\">June 23, 2026<\/span> \/PRNewswire\/ &#8212; Embecta Corp. (<b>NASDAQ: EMBC<\/b>) faces a securities class action lawsuit, which seeks to represent investors who purchased or acquired Embecta common stock between November 25, 2025 and May 4, 2026. The lawsuit follows the company&#8217;s disastrous Q2 2026 earnings report, apparently at odds with prior narrative, which triggered a massive selloff in the stock and analysts&#8217; questions.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <img decoding=\"async\" src=\"https:\/\/mmx.prnewswire.com\/media\/MS1117217\/Hagens_Berman_Sobol_Shapiro_LLP_Logo.jpg?id=OA2729030\" title=\"Class Action\" alt=\"Class Action\" \/>\n        <\/p>\n<\/p><\/div>\n<p>These developments have prompted national shareholder rights firm Hagens Berman to open an investigation into claims that Embecta violated the federal securities laws.<\/p>\n<p>The firm encourages Embecta investors who suffered substantial losses to <a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4717638-1&amp;h=1900508709&amp;u=https%3A%2F%2Fwww.hbsslaw.com%2Finvestor-fraud%2Fembc&amp;a=submit+your+losses+now\" target=\"_blank\" rel=\"nofollow\">submit your losses now<\/a>.<\/p>\n<p>\n        <b>Class Period: <\/b>Nov. 25, 2025 \u2013 May 4, 2026<br \/><b>Lead Plaintiff Deadline: <\/b>Aug. 17, 2026<br \/><b>Visit:<\/b><a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4717638-1&amp;h=3806011589&amp;u=http%3A%2F%2Fwww.hbsslaw.com%2Finvestor-fraud%2Fembc&amp;a=www.hbsslaw.com%2Finvestor-fraud%2Fembc\" target=\"_blank\" rel=\"nofollow\">www.hbsslaw.com\/investor-<span>fraud<\/span>\/embc<\/a><br \/><b>Contact the Firm Now: <\/b><a href=\"mailto:EMBC@hbsslaw.com\" target=\"_blank\" rel=\"nofollow\">EMBC@hbsslaw.com<\/a><br \/>\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0844-916-0895<\/p>\n<p>\n        <b>Embecta Corp. (EMBC) Securities Class Action:<\/b>\n      <\/p>\n<p>Embecta is a global medical device company whose core business product is pen needles \u2013 sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. In the past, pen needle revenues have comprised over 70% of the company&#8217;s total revenues.<\/p>\n<p>The litigation&#8217;s primary focus is on the propriety of Embecta&#8217;s Class Period repeated assurances that &#8220;insulin pens have been stable [\u2026] showing the underlying resilience and the durability of that portfolio[]&#8221; and &#8220;our pen needle business is incredibly resolute.&#8221; This narrative formed the basis for the company&#8217;s February 5, 2026 guidance reiterating 2026 adjusted EPS of $2.80 &#8211; $3.00.\u00a0 The company also touted maintenance of its dividend within its capital allocation plans as a return of capital to shareholders.<\/p>\n<p>The complaint <span>alleges<\/span> the company&#8217;s assurances and guidance were misleading when given because Embecta knew or recklessly disregarded that weaknesses in the pen needle market was likely to significantly disrupt the company&#8217;s annual guidance and Q2 results.<\/p>\n<p>On May 5, 2026, investors&#8217; expectations vanished. That day, Embecta reported Q2 2026 adjusted EPS of $0.27, a staggering sequential and year-over-year decline of about 61%. In contrast to the company&#8217;s assurances of stability, resilience, and durability, Embecta&#8217;s pen needles revenues also suffered massive sequential and year-over-year declines. Of additional concern, Embecta slashed its 2026 adjusted EPS guidance to $1.55 &#8211; $1.75, or down roughly 43% at the mid-point, and reduced its dividend by 93% to just $0.01.<\/p>\n<p>In response, the market sent the price of Embecta shares tumbling, with one prominent analyst who downgraded the company highlighting Embecta management&#8217;s &#8220;need to rebuild investor credibility on commercial execution and the profitability outlook.&#8221;<\/p>\n<p>&#8220;Our investigation is focused the extent to which and when Embecta and its management knew about pen needle and U.S. business revenue headwinds, and whether they were sufficiently transparent about those risks,&#8221; said <a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4717638-1&amp;h=3845818848&amp;u=https%3A%2F%2Fwww.hbsslaw.com%2Fattorneys%2Freed-kathrein&amp;a=Reed+Kathrein\" target=\"_blank\" rel=\"nofollow\"><b>Reed Kathrein<\/b><\/a>, the Hagens Berman partner leading the firm&#8217;s investigation.<\/p>\n<p>If you invested in Embecta and have substantial losses, or have knowledge that will assist the firm&#8217;s investigation, <a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4717638-1&amp;h=1900508709&amp;u=https%3A%2F%2Fwww.hbsslaw.com%2Finvestor-fraud%2Fembc&amp;a=submit+your+losses+now\" target=\"_blank\" rel=\"nofollow\">submit your losses now<\/a> \u00bb<\/p>\n<p>If you&#8217;d like more information and answers to other frequently asked questions about the Embecta case and the firm&#8217;s investigation, <a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4717638-1&amp;h=4003268317&amp;u=https%3A%2F%2Fwww.hbsslaw.com%2Fcases%2Fembecta-corp-embc-securities-class-action&amp;a=read+more+%C2%BB\" target=\"_blank\" rel=\"nofollow\">read more \u00bb<\/a><\/p>\n<p>\n        <b>Whistleblowers: <\/b>Persons with non-public information regarding Embecta should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at <b>844-916-0895<\/b> or email <a href=\"mailto:EMBC@hbsslaw.com\" target=\"_blank\" rel=\"nofollow\">EMBC@hbsslaw.com<\/a>.<\/p>\n<p>\n        <a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4717638-1&amp;h=2129197956&amp;u=https%3A%2F%2Fwww.hbsslaw.com%2F&amp;a=About+Hagens+Berman\" target=\"_blank\" rel=\"nofollow\">About Hagens Berman<\/a><br \/>\n        <br \/>Hagens Berman is a global plaintiffs&#8217; rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman&#8217;s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at\u00a0<a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4717638-1&amp;h=2605717181&amp;u=https%3A%2F%2Fwww.hbsslaw.com%2F&amp;a=hbsslaw.com\" target=\"_blank\" rel=\"nofollow\">hbsslaw.com<\/a>. Follow the firm for updates and news at\u00a0<a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4717638-1&amp;h=2714622387&amp;u=https%3A%2F%2Fwww.twitter.com%2FClassActionLaw&amp;a=%40ClassActionLaw\" target=\"_blank\" rel=\"nofollow\">@ClassActionLaw<\/a>.<\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/edge.prnewswire.com\/c\/img\/favicon.png?sn=SF90072&amp;sd=2026-06-23\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business----hbss-302807844.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business&#8212;-hbss-302807844.html<\/a><\/p>\n<p>SOURCE Hagens Berman Sobol Shapiro LLP<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=SF90072&amp;Transmission_Id=202606231152PR_NEWS_USPR_____SF90072&amp;DateId=20260623\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire SAN FRANCISCO, June 23, 2026 \/PRNewswire\/ &#8212; Embecta Corp. (NASDAQ: EMBC) faces a securities class action lawsuit, which seeks to represent investors who purchased or acquired Embecta common stock between November 25, 2025 and May 4, 2026. The lawsuit follows the company&#8217;s disastrous Q2 2026 earnings report, apparently at odds with prior narrative, which triggered a massive selloff in the stock and analysts&#8217; questions. These developments have prompted national shareholder rights firm Hagens Berman to open an investigation into claims that Embecta violated the federal securities laws. The firm encourages Embecta investors who suffered substantial losses to submit your losses now. Class Period: Nov. 25, 2025 \u2013 May 4, 2026Lead Plaintiff Deadline: Aug. 17, 2026Visit:www.hbsslaw.com\/investor-fraud\/embcContact the Firm Now: &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss-3\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Embecta Corp. (EMBC) Faces Securities Class Action for Allegedly Concealing Competitive Threats to Pen Needle Business &#8212; HBSS&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-974888","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Embecta Corp. (EMBC) Faces Securities Class Action for Allegedly Concealing Competitive Threats to Pen Needle Business - HBSS - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss-3\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Embecta Corp. (EMBC) Faces Securities Class Action for Allegedly Concealing Competitive Threats to Pen Needle Business - HBSS - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire SAN FRANCISCO, June 23, 2026 \/PRNewswire\/ &#8212; Embecta Corp. (NASDAQ: EMBC) faces a securities class action lawsuit, which seeks to represent investors who purchased or acquired Embecta common stock between November 25, 2025 and May 4, 2026. The lawsuit follows the company&#8217;s disastrous Q2 2026 earnings report, apparently at odds with prior narrative, which triggered a massive selloff in the stock and analysts&#8217; questions. These developments have prompted national shareholder rights firm Hagens Berman to open an investigation into claims that Embecta violated the federal securities laws. The firm encourages Embecta investors who suffered substantial losses to submit your losses now. Class Period: Nov. 25, 2025 \u2013 May 4, 2026Lead Plaintiff Deadline: Aug. 17, 2026Visit:www.hbsslaw.com\/investor-fraud\/embcContact the Firm Now: &hellip; Continue reading &quot;Embecta Corp. (EMBC) Faces Securities Class Action for Allegedly Concealing Competitive Threats to Pen Needle Business &#8212; HBSS&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss-3\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-23T15:55:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mmx.prnewswire.com\/media\/MS1117217\/Hagens_Berman_Sobol_Shapiro_LLP_Logo.jpg?id=OA2729030\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss-3\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss-3\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Embecta Corp. (EMBC) Faces Securities Class Action for Allegedly Concealing Competitive Threats to Pen Needle Business &#8212; HBSS\",\"datePublished\":\"2026-06-23T15:55:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss-3\\\/\"},\"wordCount\":656,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss-3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mmx.prnewswire.com\\\/media\\\/MS1117217\\\/Hagens_Berman_Sobol_Shapiro_LLP_Logo.jpg?id=OA2729030\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss-3\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss-3\\\/\",\"name\":\"Embecta Corp. (EMBC) Faces Securities Class Action for Allegedly Concealing Competitive Threats to Pen Needle Business - HBSS - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss-3\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss-3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mmx.prnewswire.com\\\/media\\\/MS1117217\\\/Hagens_Berman_Sobol_Shapiro_LLP_Logo.jpg?id=OA2729030\",\"datePublished\":\"2026-06-23T15:55:15+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss-3\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss-3\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss-3\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mmx.prnewswire.com\\\/media\\\/MS1117217\\\/Hagens_Berman_Sobol_Shapiro_LLP_Logo.jpg?id=OA2729030\",\"contentUrl\":\"https:\\\/\\\/mmx.prnewswire.com\\\/media\\\/MS1117217\\\/Hagens_Berman_Sobol_Shapiro_LLP_Logo.jpg?id=OA2729030\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss-3\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Embecta Corp. (EMBC) Faces Securities Class Action for Allegedly Concealing Competitive Threats to Pen Needle Business &#8212; HBSS\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Embecta Corp. (EMBC) Faces Securities Class Action for Allegedly Concealing Competitive Threats to Pen Needle Business - HBSS - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss-3\/","og_locale":"en_US","og_type":"article","og_title":"Embecta Corp. (EMBC) Faces Securities Class Action for Allegedly Concealing Competitive Threats to Pen Needle Business - HBSS - Market Newsdesk","og_description":"PR Newswire SAN FRANCISCO, June 23, 2026 \/PRNewswire\/ &#8212; Embecta Corp. (NASDAQ: EMBC) faces a securities class action lawsuit, which seeks to represent investors who purchased or acquired Embecta common stock between November 25, 2025 and May 4, 2026. The lawsuit follows the company&#8217;s disastrous Q2 2026 earnings report, apparently at odds with prior narrative, which triggered a massive selloff in the stock and analysts&#8217; questions. These developments have prompted national shareholder rights firm Hagens Berman to open an investigation into claims that Embecta violated the federal securities laws. The firm encourages Embecta investors who suffered substantial losses to submit your losses now. Class Period: Nov. 25, 2025 \u2013 May 4, 2026Lead Plaintiff Deadline: Aug. 17, 2026Visit:www.hbsslaw.com\/investor-fraud\/embcContact the Firm Now: &hellip; Continue reading \"Embecta Corp. (EMBC) Faces Securities Class Action for Allegedly Concealing Competitive Threats to Pen Needle Business &#8212; HBSS\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss-3\/","og_site_name":"Market Newsdesk","article_published_time":"2026-06-23T15:55:15+00:00","og_image":[{"url":"https:\/\/mmx.prnewswire.com\/media\/MS1117217\/Hagens_Berman_Sobol_Shapiro_LLP_Logo.jpg?id=OA2729030","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss-3\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss-3\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Embecta Corp. (EMBC) Faces Securities Class Action for Allegedly Concealing Competitive Threats to Pen Needle Business &#8212; HBSS","datePublished":"2026-06-23T15:55:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss-3\/"},"wordCount":656,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss-3\/#primaryimage"},"thumbnailUrl":"https:\/\/mmx.prnewswire.com\/media\/MS1117217\/Hagens_Berman_Sobol_Shapiro_LLP_Logo.jpg?id=OA2729030","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss-3\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss-3\/","name":"Embecta Corp. (EMBC) Faces Securities Class Action for Allegedly Concealing Competitive Threats to Pen Needle Business - HBSS - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss-3\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss-3\/#primaryimage"},"thumbnailUrl":"https:\/\/mmx.prnewswire.com\/media\/MS1117217\/Hagens_Berman_Sobol_Shapiro_LLP_Logo.jpg?id=OA2729030","datePublished":"2026-06-23T15:55:15+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss-3\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss-3\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss-3\/#primaryimage","url":"https:\/\/mmx.prnewswire.com\/media\/MS1117217\/Hagens_Berman_Sobol_Shapiro_LLP_Logo.jpg?id=OA2729030","contentUrl":"https:\/\/mmx.prnewswire.com\/media\/MS1117217\/Hagens_Berman_Sobol_Shapiro_LLP_Logo.jpg?id=OA2729030"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/embecta-corp-embc-faces-securities-class-action-for-allegedly-concealing-competitive-threats-to-pen-needle-business-hbss-3\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Embecta Corp. (EMBC) Faces Securities Class Action for Allegedly Concealing Competitive Threats to Pen Needle Business &#8212; HBSS"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/974888","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=974888"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/974888\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=974888"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=974888"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=974888"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}